# A First-Time-in-Human Study to Assess the Safety and Tolerability of PP 1420 in Healthy Subjects

> **NCT01052493** · PHASE1 · COMPLETED · sponsor: **Imperial College London** · enrollment: 13 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** PP 1420
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01052493
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-10-18
- **Final completion:** 2010-10-18
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2021-02-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01052493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01052493, "A First-Time-in-Human Study to Assess the Safety and Tolerability of PP 1420 in Healthy Subjects". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT01052493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*